Focused Large Cap Value Fund
Daily price w/o sales charge as of 01/26/2023
$10.15
$0.05
YTD Returns w/o sales charge as of 01/26/2023
4.96%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 12/30/2022
- Total Net Assets
- $20.95 M
- Inception Date
- 08/01/2019
- Dividend Frequency
- Annually
- Number of Holdings
- 37
- Minimum Initial Investment
- $1,500+
Expense Ratioas of 12/31/2022
Expense ratio details, Click here.
The net expense ratio takes into account contractual fee waivers/expense reimbursements that currently are scheduled to remain in place through 02/28/2023. For periods when fees and expenses were waived and/or reimbursed, the Fund benefited by not bearing such expenses. Without such fee waivers/reimbursements, performance would have been lower.
Fund Expense Ratio :
0.93%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | -10.35% | -10.35% | 6.22% | - | - | 6.97% |
Lipper Category Avg. Large-Cap Value Funds | -6.88% | -6.88% | 6.93% | - | - | - |
Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | - | - | 7.60% |
w/ sales charge | -15.51% | -15.51% | 4.13% | - | - | 5.13% |
Fund Expense Ratio :
0.93%
Fund Expense Ratio :
0.93%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | -10.35% | -10.35% | 6.22% | - | - | 6.97% |
Lipper Category Avg. Large-Cap Value Funds | -6.88% | -6.88% | 6.93% | - | - | - |
Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | - | - | 7.60% |
w/ sales charge | -15.51% | -15.51% | 4.13% | - | - | 5.13% |
Fund Expense Ratio :
0.93%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/30/2022
Holding | Assets |
---|---|
Allstate Corp/The | 4.4% |
Raytheon Technologies Corp | 4.4% |
Ameriprise Financial Inc | 4.2% |
AbbVie Inc | 3.4% |
CVS Health Corp | 3.4% |
KKR & Co Inc | 3.4% |
AerCap Holdings NV | 3.1% |
JPMorgan Chase & Co | 3.1% |
Parker-Hannifin Corp | 3.1% |
Wells Fargo & Co | 3.1% |
Sector Allocationas of 12/30/2022
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate | 0.0% | |
Utilities |
![]() |
|
Consumer Discretionary |
![]() |
|
Consumer Staples |
![]() |
|
Energy |
![]() |
|
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials |
![]() |
INVESTMENT TEAM



Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.93%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | -10.35% | -10.35% | 6.22% | - | - | 6.97% |
Lipper Category Avg. Large-Cap Value Funds | -6.88% | -6.88% | 6.93% | - | - | - |
Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | - | - | 7.60% |
w/ sales charge | -15.51% | -15.51% | 4.13% | - | - | 5.13% |
Fund Expense Ratio :
0.93%
Fund Expense Ratio :
0.93%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 07/31/2019 |
---|
w/o sales charge | -10.35% | -10.35% | 6.22% | - | - | 6.97% |
Lipper Category Avg. Large-Cap Value Funds | -6.88% | -6.88% | 6.93% | - | - | - |
Russell 1000® Value Index | -7.54% | -7.54% | 5.96% | - | - | 7.60% |
w/ sales charge | -15.51% | -15.51% | 4.13% | - | - | 5.13% |
Fund Expense Ratio :
0.93%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
The Fund changed its investment strategy on 07/31/2019. Performance is calculated from this date.
Year | Fund Returns | Russell 1000® Value Index |
---|
2022 | -10.35% | -7.54% |
2021 | 27.77% | 25.16% |
2020 | 4.61% | 2.80% |
2019 | 5.08% | 26.54% |
Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
---|
2023 | - | - | - | - | 4.96% |
2022 | -1.56% | -13.47% | -7.02% | 13.21% | -10.35% |
2021 | 14.47% | 4.99% | -0.38% | 6.72% | 27.77% |
2020 | -36.16% | 28.97% | 2.09% | 24.45% | 4.61% |
2019 | - | - | - | 5.86% | 5.08% |
Year | Fund Returns | Russell 1000® Value Index |
---|
2022 | -10.35% | -7.54% |
2021 | 27.77% | 25.16% |
2020 | 4.61% | 2.80% |
2019 | 5.08% | 26.54% |
Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
---|
2023 | - | - | - | - | 4.96% |
2022 | -1.56% | -13.47% | -7.02% | 13.21% | -10.35% |
2021 | 14.47% | 4.99% | -0.38% | 6.72% | 27.77% |
2020 | -36.16% | 28.97% | 2.09% | 24.45% | 4.61% |
2019 | - | - | - | 5.86% | 5.08% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
NAV HISTORICAL PRICES
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
Allstate Corp/The | Financials | 4.4% |
Raytheon Technologies Corp | Industrials | 4.4% |
Ameriprise Financial Inc | Financials | 4.2% |
AbbVie Inc | Health Care | 3.4% |
CVS Health Corp | Health Care | 3.4% |
KKR & Co Inc | Financials | 3.4% |
AerCap Holdings NV | Industrials | 3.1% |
JPMorgan Chase & Co | Financials | 3.1% |
Parker-Hannifin Corp | Industrials | 3.1% |
Wells Fargo & Co | Financials | 3.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
Allstate Corp/The | Financials | 4.8% |
Raytheon Technologies Corp | Industrials | 4.0% |
Ameriprise Financial Inc | Financials | 4.0% |
CVS Health Corp | Health Care | 3.9% |
Wells Fargo & Co | Financials | 3.7% |
KKR & Co Inc | Financials | 3.5% |
NRG Energy Inc | Utilities | 3.5% |
T-Mobile US Inc | Communication Services | 3.3% |
AbbVie Inc | Health Care | 3.2% |
Chesapeake Energy Corp | Energy | 3.1% |
Centene Corp | Health Care | 3.0% |
Popular Inc | Financials | 2.9% |
Parker-Hannifin Corp | Industrials | 2.9% |
Fiserv Inc | Information Technology | 2.9% |
Pfizer Inc | Health Care | 2.9% |
BJ's Wholesale Club Holdings Inc | Consumer Staples | 2.9% |
Organon & Co | Health Care | 2.8% |
Target Corp | Consumer Discretionary | 2.8% |
General Motors Co | Consumer Discretionary | 2.5% |
AerCap Holdings NV | Industrials | 2.5% |
Eagle Materials Inc | Materials | 2.4% |
Masco Corp | Industrials | 2.4% |
Schlumberger NV | Energy | 2.3% |
Valvoline Inc | Materials | 2.2% |
Cisco Systems Inc | Information Technology | 2.1% |
Caesars Entertainment Inc | Consumer Discretionary | 2.0% |
Alphabet Inc | Communication Services | 2.0% |
Euronet Worldwide Inc | Information Technology | 1.9% |
Assurant Inc | Financials | 1.9% |
Micron Technology Inc | Information Technology | 1.8% |
Shell PLC | Energy | 1.8% |
Horizon Therapeutics Plc | Health Care | 1.5% |
Pioneer Natural Resources Co | Energy | 1.5% |
Gilead Sciences Inc | Health Care | 1.4% |
Spectrum Brands Holdings Inc | Consumer Staples | 1.2% |
Alcoa Corp | Materials | 0.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/30/2022
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Real Estate | 0.0% | |
Utilities |
![]() |
|
Consumer Discretionary |
![]() |
|
Consumer Staples |
![]() |
|
Energy |
![]() |
|
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials |
![]() |
PORTFOLIO DETAILS as of 12/30/2022
- Total Net Assets
- $20.95 M
- Number of Holdings
- 37
- Weighted Average Market Cap.
- 106.8 B
- P/B Ratio
- 2.5x
- P/E Ratio
- 14.9x
To view definitions for the above Portfolio Details, Click here.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/30/2022
Contributors
Holding | Contribution |
---|---|
Horizon Pharma plc | 1.2% |
Schlumberger NV | 1.2% |
Aercap Holdings Nv | 0.9% |
United Technologies Corp. | 0.8% |
AbbVie, Inc. | 0.8% |
Detractors
Holding | Contribution |
---|---|
NRG Energy, Inc. | -0.6% |
Popular, Inc. | -0.3% |
Bjs Whsl Club Hldgs Inc | -0.3% |
Alphabet Inc | -0.3% |
Assurant, Inc. | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
Focused Large Cap Value Fund | Benchmark | Variance | |||||
---|---|---|---|---|---|---|---|
Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to Lord Abbett Affiliated Fund Performance Results for the Fund's longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 01/26/2023
Sales Charge | Dealer's Concession | Prices at Breakpoint | |
---|---|---|---|
Less than $50,000 | 5.75% | 5.00% | $10.77 |
$50,000 to $99,999 | 4.75% | 4.00% | $10.66 |
$100,000 to $249,999 | 3.95% | 3.25% | $10.57 |
$250,000 to $499,999 | 2.75% | 2.25% | $10.44 |
$500,000 to $999,999 | 1.95% | 1.75% | $10.35 |
$1,000,000 to $5,000,000 | 0.00% | 1.00% | $10.15 |
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 12/31/2022
Expense ratio details, Click here.
The net expense ratio takes into account contractual fee waivers/expense reimbursements that currently are scheduled to remain in place through 02/28/2023. For periods when fees and expenses were waived and/or reimbursed, the Fund benefited by not bearing such expenses. Without such fee waivers/reimbursements, performance would have been lower.
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
0Documents selected
|
Order | ||||
---|---|---|---|---|---|
n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
|||||
n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
|||||
Annual Report
Publish Date:11/03/2015
|
|||||
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
Fact Sheet
Publish Date:11/03/2015
|